References
- 1. D. M. Campoli-Richards, J. P. Monk, A. Price, P. Benfield, P. A. Todd and A. Ward, Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use, Drugs35 (1988) 373–447; https://doi.org/10.2165/00003495-198835040-0000310.2165/00003495-198835040-00003
- 2. A. D. Pranger, J. W. C. Alffenaar and R. E. Aarnoutse, Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: A pharmacokinetic and pharmacodynamics approach, Curr. Pharm. Des. 17 (2011) 2900–2930; https://doi.org/10.2174/13816121179747020010.2174/138161211797470200
- 3. L. D. Ross and C. M. Riley, Aqueous solubilities of some variously substituted quinolone antimicrobials, Int. J. Pharm. 63 (1990) 237–250; https://doi.org/10.1016/0378-5173(90)90130-V10.1016/0378-5173(90)90130-V
- 4. A. O. Surov, A. N. Manin, A. P. Voronin, K. V. Drozd, A. A. Simagina, A. V. Churakov and G. L. Perlovich, Pharmaceutical salts of ciprofloxacin with dicarboxylic acids, Eur. J. Pharm. Sci. 77 (2015) 112–121; https://doi.org/10.1016/j.ejps.2015.06.00410.1016/j.ejps.2015.06.004
- 5. M. E. Olivera, R. H. Manzo, H. E. Junginger, K. K. Midha, V. P. Shah, S. Stavchansky, J. B. Dressman and D. M. Barends, Biowaiver monographs for immediate release solid oral dosage forms: ciprofloxacin hydrochloride, J Pharm Sci. 100 (2011) 22–33; https://doi.org/10.1002/jps.2225910.1002/jps.22259
- 6. H. Arakawa, Y. Shirasaka and M. Haga, Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Biopharm. Drug Dispos. 33 (2012) 332–341; https://doi.org/10.1002/bdd.180910.1002/bdd.1809
- 7. Z. Iqbal, A. Khan, A. Naz, J. Khan and G. Khan, Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, two-period crossover study in healthy adult volunteers, Clin. Drug Invest. 29 (2009) 275–281; https://doi.org/10.2165/00044011-200929040-0000610.2165/00044011-200929040-00006
- 8. D. El-Sabawi, R. Abu-Dahab, A. G. Al Bakri and I. I. Hamdan, Studies on the interaction between ciprofloxacin hydrochloride and diclofenac sodium, Trop. J. Pharm. Res. 18 (2019) 377–384; https://doi.org/10.4314/tjpr.v18i2.2210.4314/tjpr.v18i2.22
- 9. P. P. Bag, S. Ghosh, H. Khan, R. Devarapalliand and C. M. Reddy, Drug-drug salt forms of ciprofloxacin with diflunisal and indoprofen, Cryst. Eng. Commun. 16 (2014) 7393–7396; https://doi.org/10.1039/C4CE00631C10.1039/C4CE00631C
- 10. C. Florindo, A. Costa, C. Matos, S. L. Nunes, A. N. Matias, C. M. Duarte, L. P. Rebelo, L. C. Branco and I. M. Marrucho, Novel organic salts based on fluoroquinolone drugs: synthesis, bioavailability and toxicological profiles, Int. J. Pharm.469 (2014) 179–189; https://doi.org/10.1016/j.ijpharm.2014.04.03410.1016/j.ijpharm.2014.04.034
- 11. M. Ali and M. E. Byrne, Challenges and solutions in topical ocular drug-delivery systems, Expert. Rev. Clin. Pharmacol. 1 (2008) 145–161; https://doi.org/10.1586/17512433.1.1.14510.1586/17512433.1.1.145
- 12. A. A. Firsov, I. Y. Lubenko, M. V. Smirnova, E. N. Strukova and S. H. Zinner, Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window, J. Antimicrob. Chemother.52 (2008) 1924–1928; https://doi.org/10.1128/AAC.01371-0710.1128/AAC.01371-07
- 13. N. A. Lozano-Huntelman, N. Singh, A. Valencia, P. Mira, M. Sakayan, I. Boucher, S. Tang, K. Brennan, C. Gianvecchio and S. Fitz-Gibbon, Evolution of antibiotic cross-resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window, Evol. Appl. 13 (2020) 808–823; https://doi.org/10.1111/eva.1290310.1111/eva.12903
- 14. A. Espinel-Ingroff, A. Fothergill, M. Ghannoum, E. Manavathu, L. Ostrosky-Zeichner and M. Pfaller, Quality control and reference guidelines for CLSI broth microdilution method (m38-a document) for susceptibility testing of anidulafungin against molds, J. Clin. Microbiol. 45 (2007) 2180–2182; https://doi.org/10.1128/JCM.00399-0710.1128/JCM.00399-07
- 15. A. Wolfe, G. H. Shimer and J. T. Meehan, Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA, Biochemistry26 (1987) 6392–6396; https://doi.org/10.1021/bi00394a01310.1021/bi00394a013
- 16. P. Gould, Salt selection for basic drugs, Int. J. Pharm. 33 (1986) 201–217; https://doi.org/10.1016/0378-5173(86)90055-410.1016/0378-5173(86)90055-4
- 17. K. Zhang, L. Dai and N. Chetwyn, Simultaneous determination of positive and negative pharmaceutical counter ions using mixed-mode chromatography coupled with charged aerosol detector, J. Chromatogr. A1217 (2010) 5776–5784; https://doi.org/10.1016/j.chroma.2010.07.03510.1016/j.chroma.2010.07.035
- 18. S. Bouabdallah, H. Trabelsi, M. R. Driss and S. Touil, Determination and degradation study of enalapril maleate by high performance liquid chromatography, Pharm. Chem. J. 51 (2017) 735–741; https://doi.org/10.1007/s11094-017-1684-210.1007/s11094-017-1684-2
- 19. B. W. Pack and D. S. Risley, Evaluation of a monolithic silica column operated in the hydrophilic interaction chromatography mode with evaporative light scattering detection for the separation and detection of counter-ions, J. Chromatogr. A1073 (2005) 269–275; https://doi.org/10.1016/j.chroma.2004.09.06110.1016/j.chroma.2004.09.061
- 20. M. Takač, Effects of substituents on the NMR features of basic bicyclic ring systems of fluoroquinolone antibiotics and the relationships between NMR chemical shifts, molecular descriptors and drug-likeness parameters, Acta Pharm. 60 (2010) 237–254; https://doi.org/10.2478/v10007-010-0023-x10.2478/v10007-010-0023-x
- 21. S. Durgapal, S. Mukhopadhyay and L. Goswami, Preparation, characterization and evaluation of floating microparticles of ciprofloxacin, Int. J. Appl. Pharm. 9 (2017) 1–8; https://doi.org/10.22159/ijap.2017v9i1.1418310.22159/ijap.2017v9i1.14183
- 22. H. Changa, W. T. Jianga, Z. Lib, C. Y. Kuoc, Q. Wud, J. S. Jeana and G. Lvea, Interaction of ciprofloxacin and probe compounds with palygorskite PFl-1, J. Hazard. Mat. 303 (2016) 55–63; https://doi.org/10.1016/j.jhazmat.2015.10.01210.1016/j.jhazmat.2015.10.012
- 23. M. P. López-Gresa, R. Ortiz and L. Perelló, Interactions of metal ions with two quinolone antimicrobial agents (cinoxacin and ciprofloxacin). Spectroscopic and X-ray structural characterization. Antibacterial studies, J. Inorg. Biochem.92 (2002) 65–74; https://doi.org/10.1016/S0162-0134(02)00487-710.1016/S0162-0134(02)00487-7
- 24. K. Karimi, E.Pallagi, P. Szabó-Révész, I. Csóka and R. Ambrus, Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach, Drug Des. Dev. Ther.10 (2016) 3331–3343; https://doi.org/10.2147/DDDT.S11644310.2147/DDDT.S116443
- 25. J. G. Holler, S. B. Christensen, H. C. Slotved, H. B. Rasmussen, A. Gúzman, C. E. Olsen, B. Petersen and P. Mølgaard, Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees, J. Antimicrob. Chemother.67 (2012) 1138–1144; https://doi.org/10.1093/jac/dks00510.1093/jac/dks005
- 26. G. P. Gesu, F. Marchetti, L. Piccoli and A. Cavallero, Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories, J. Antimicrob. Chemother.47 (2003) 816–819; https://doi.org/10.1128/aac.47.2.816-819.200310.1128/AAC.47.2.816-819.2003
- 27. J. Vázquez, S. Merino, Ò. Doměnech, M. Berlanga, M. Viñas and M. Montero, Determination of the partition coefficients of a homologous series of ciprofloxacin: influence of the N-4 piperazinyl alkylation on the antimicrobial activity, Int. J. Pharm.220 (2001) 53–62; https://doi.org/10.1016/s0378-5173(01)00646-910.1016/S0378-5173(01)00646-9
- 28. I. Vilfan, P. Drevenšek, I. Turel and U. N. Poklar, Characterization of ciprofloxacin binding to the linear single- and double-stranded DNA, Biochim. Biophys. Acta1628 (2003) 111–122; https://doi.org/10.1016/s0167-4781(03)00135-010.1016/S0167-4781(03)00135-0
- 29. D. Hooper, Mode of action of fluoroquinolones, Drugs58 (1999) 6–10; https://doi.org/10.2165/00003495-199958002-0000210.2165/00003495-199958002-00002
- 30. K. J. Aldred, R. J. Kerns and N. Osheroff, Mechanism of quinolone action and resistance, Biochemistry53 (2014) 1565–1574;https://doi.org/10.1021/bi500056410.1021/bi5000564
- 31. C. Noble, F. Barnard and A. Maxwell, Quinolone-DNA interaction: sequence-dependent binding to single-stranded DNA reflects the interaction within the gyrase-DNA complex, Antimicrob. Agents Chemother. 47 (2003) 854–862; https://doi.org/10.1128/aac.47.3.854-862.200310.1128/AAC.47.3.854-862.2003